Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · IEX Real-Time Price · USD
4.040
-0.190 (-4.49%)
At close: Jul 19, 2024, 4:00 PM
4.060
+0.020 (0.50%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $174.50M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $41.87M with 11.23% year-over-year growth. In the year 2023, Adaptive Biotechnologies had annual revenue of $170.28M.

Revenue (ttm)
$174.50M
Revenue Growth
-5.33%
P/S Ratio
3.41
Revenue / Employee
$246,124
Employees
709
Market Cap
595.37M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 202098.38M13.31M15.65%
Dec 31, 201985.07M29.41M52.83%
Dec 31, 201855.66M17.22M44.77%
Dec 31, 201738.45M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ADPT News

More News